Business - Briefly   

Orchid JV's achievement

CHENNAI: Orchid Chemicals and Pharmaceuticals Ltd. (Orchid) on Thursday announced that its U.S. discovery joint venture, Bexel Pharmaceuticals Inc., that has been working on a novel anti-diabetic molecule (BLX-1002), has successfully completed phase 1(a) clinical trials (double-blinded placebo controlled) and moved the molecule into phase 1(b) clinical trials in Europe. The company has also been granted the certificate of suitability (CoS) by the European Directorate for the Quality of Medicines (EDQM) for its API product Cefadroxil Monohydrate.

Our Bureau

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

• Current account surplus doubles in Q3
• High GDP growth propels Sensex
• SAIL output at 11 m tonnes
• Maruti's record sales
• Forex reserves up $26.4 b in April-December
• PFC net at Rs. 1601 cr.
• Alcatel sets up lab at SlashSupport facility
• Abolition of MAT sought
• HAL, BEL, BEML announce higher profits
• Bullion rates
• Stock Market Index
• Infosys results on April 12
• RIL's new gas discoveries
• Aigner forays into India
• SBI MD and Group Executive
• Google to offer free e-mail
• Sony sues Kodak
• Garment exporters seek relief
• Coimbatore Zone excise revenue up
• Orchid JV's achievement
• Chola Growth Fund pays 10 p.c.
• Future holds for cash crops
• Idea's Delhi subscriber base up
• Agilent's chip design centre at Gurgaon
• Crompton pact with FreeMarkets
• Zydus Cadila files 12 ANDAs
• SECL's achievement
• Idea Cellular offers unique service
• Matrix Biosciences plant on stream
• All time record for Malabar Cements
• Tata Tea launches new variety
• Cadbury hopes to retain market share
• Canara Bank launches loan scheme

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu